Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration
Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration, from the December 2008 issue of Clinical Therapeutics.
Please click here to read the abstract.
23rd annual EURETINA Congress: seeing eye to eye in Amsterdam
September 25th 2023Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops
Study: MERCURY-3 trial results support efficacy of Roclanda
September 13th 2023MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.
2 Clarke Drive
Cranbury, NJ 08512